Detalhe da pesquisa
1.
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
Blood
; 143(17): 1752-1757, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194687
2.
Progression and survival of MBL: a screening study of 10 139 individuals.
Blood
; 140(15): 1702-1709, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969843
3.
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.
Blood
; 140(2): 112-120, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427411
4.
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Blood
; 138(2): 149-159, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876228
5.
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Blood
; 138(26): 2810-2827, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407545
6.
Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
Blood
; 137(15): 2046-2056, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512457
7.
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Am J Hematol
; 98(12): 1829-1837, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665758
8.
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
N Engl J Med
; 381(5): 432-443, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31365801
9.
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.
Br J Haematol
; 195(3): 413-416, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34346084
10.
MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.
Eur J Haematol
; 107(4): 458-465, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214199
11.
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
Am J Hematol
; 96(7): 781-789, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844862
12.
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.
Br J Haematol
; 189(2): 291-302, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945802
13.
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Blood
; 131(23): 2541-2551, 2018 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674426
14.
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis.
Am J Hematol
; 94(3): 299-305, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516848
15.
20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients.
Am J Hematol
; 94(3): 286-290, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516867
16.
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide.
Am J Hematol
; 94(1): 5-9, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252953
17.
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Am J Hematol
; 94(3): 338-345, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575108
18.
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method.
Am J Hematol
; 94(4): 424-430, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30592078
19.
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.
Br J Haematol
; 183(3): 421-427, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117139
20.
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.
N Engl J Med
; 373(10): 908-19, 2015 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26332545